BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35278461)

  • 1. B7-H4 expression promotes non-small cell lung cancer progression via AMPK/mTOR signaling.
    Li M; Che N; Feng Y; Liu X; Piao L; Xuan Y; Jin Y
    Exp Mol Pathol; 2022 Apr; 125():104755. PubMed ID: 35278461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
    Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
    Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
    Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
    J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-105 promotes epithelial-mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl-1.
    Jin X; Yu Y; Zou Q; Wang M; Cui Y; Xie J; Wang Z
    J Cell Biochem; 2019 Apr; 120(4):5880-5888. PubMed ID: 30317672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H4 facilitates proliferation and metastasis of colorectal carcinoma cell through PI3K/Akt/mTOR signaling pathway.
    Li C; Zhan Y; Ma X; Fang H; Gai X
    Clin Exp Med; 2020 Feb; 20(1):79-86. PubMed ID: 31664539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-Homolog 4 Promotes Epithelial-Mesenchymal Transition and Invasion of Bladder Cancer Cells via Activation of Nuclear Factor-κB.
    Wu H; Wang X; Mo N; Zhang L; Yuan X; Lü Z
    Oncol Res; 2018 Sep; 26(8):1267-1274. PubMed ID: 29391086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
    Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
    Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer.
    Yuan L; Ye J; Fan D
    Hum Immunol; 2020 May; 81(5):254-261. PubMed ID: 32113654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis.
    Zhang J; Han L; Yu J; Li H; Li Q
    Aging (Albany NY); 2021 Apr; 13(7):10431-10449. PubMed ID: 33819917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway.
    Wang YL; Wang Q; Li H; Wang CC; Ma YL; Han Z
    Neoplasma; 2023 Feb; 70(1):46-57. PubMed ID: 36620877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
    Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
    Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells.
    Yin Y; Shi L; Yang J; Wang H; Yang H; Wang Q
    Bioengineered; 2022 Jan; 13(1):107-118. PubMed ID: 34818980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
    Song G; Fang J; Shang C; Li Y; Zhu Y; Xiu Z; Sun L; Jin N; Li X
    Exp Cell Res; 2021 Dec; 409(2):112926. PubMed ID: 34793774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.
    Peng HX; Wu WQ; Yang DM; Jing R; Li J; Zhou FL; Jin YF; Wang SY; Chu YM
    Biomed Res Int; 2015; 2015():326981. PubMed ID: 26078947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.